When a man tells you that, in ten years’ time, he envisages treating retinal diseases with a tiny inkjet printer head, you begin to wonder if he’s been drinking strong coffee with too much gusto that morning. But if that man is Keith Martin, Professor of Ophthalmology at the University of Cambridge, you need to revisit that diagnosis.
Enjoy our FREE content!
Log in or register to read this article in full and gain access to The Ophthalmologist’s entire content archive. It’s FREE and always will be!
If you don’t have an account you can:
REGISTER NOW – it’s FREE and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Ophthalmologist magazine
Or Login as a Guest or via Social Media
This will allow you to read this article but you will only have limited access to The Ophthalmologist.Login as Guest Twitter LinkedIn Google+ Facebook